Polymorphism in the IL10 promoter region and early markers of atherosclerosis: The Cardiovascular Risk in Young Finns Study

Atherosclerosis

Volumn 208, Issue 1, 2010, Pages 190-196

  Heiskanen, Miikael ^a   Kähönen, Mika ^a,b   Hurme, Mikko ^a   Lehtimäki, Terho ^a,b   Mononen, Nina ^b   Juonala, Markus ^c   Hutri Kähönen, Nina ^a,b   Viikari, Jorma ^c   Raitakari, Olli ^c   Hulkkonen, Janne ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Atherosclerosis; Blood pressure; Compliance; Cytokine; HDL; Hypertension; Interleukin 10; Polymorphism; Stiffness index; Young's elastic modulus

Indexed keywords

ADENINE; CYTOSINE; GLUCOSE; GUANINE; INSULIN; INTERLEUKIN 10; LIPID; THYMINE;

ADULT; AGE DISTRIBUTION; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE MARKER; ELASTICITY; FEMALE; FINLAND; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HEREDITY; HETEROZYGOTE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG MODULUS;

ADULT; ATHEROSCLEROSIS; FEMALE; GENETIC MARKERS; HUMANS; INTERLEUKIN-10; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 73449119229     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.06.032     Document Type: Article

References (44)

1. Powrie F., Bean A., and Moore K. Interleukin-10. In: Remick D., and Friedland J. (Eds). Cytokines in health and disease. 2nd ed. (1997), Marcel Dekker Inc., New York 143-152
2. Rousset F., Garcia E., Defrance T., et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89 (1992) 1890-1893
3. Westendorp R.G., Langermans J.A., Huizinga T.W., et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349 (1997) 170-173
4. Turner D.M., Williams D.M., Sankaran D., et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 (1997) 1-8
5. Edwards-Smith C.J., Jonsson J.R., Purdie D.M., et al. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30 (1999) 526-530
6. Hulkkonen J., Pertovaara M., Antonen J., et al. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjogren's syndrome. Arthritis Rheum 44 (2001) 176-179
7. Caligiuri G., Rudling M., Ollivier V., et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 9 (2003) 10-17
8. Pinderski Oslund L.J., Hedrick C.C., Olvera T., et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol 19 (1999) 2847-2853
9. Ambrosius W., Kazmierski R., Michalak S., and Kozubski W. Anti-inflammatory cytokines in subclinical carotid atherosclerosis. Neurology 66 (2006) 1946-1948
10. Heeschen C., Dimmeler S., Hamm C.W., et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107 (2003) 2109-2114
11. Smith D.A., Irving S.D., Sheldon J., Cole D., and Kaski J.C. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 104 (2001) 746-749
12. Lakoski S.G., Liu Y., Brosnihan K.B., and Herrington D.M. Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study. Atherosclerosis 197 (2008) 443-447
13. Altun B., Yilmaz R., Kahraman S., et al. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients. Transpl Int 18 (2005) 681-689
14. George S., Ruan X.Z., Navarrete C., et al. Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10. Tissue Antigens 63 (2004) 470-475
15. Trompet S., Pons D., DEC A.J., et al. Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann N Y Acad Sci 1100 (2007) 189-198
16. Blanco E., Monux G., Mas A., et al. Role of IL-10 promoter polymorphisms in the development of severe aorto-iliac occlusive disease. Hum Immunol 69 (2008) 651-654
17. Hirashiki A., Yamada Y., Murase Y., et al. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 42 (2003) 1429-1437
18. Koch W., Kastrati A., Bottiger C., et al. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 159 (2001) 137-144
19. Oda K., Tanaka N., Arai T., et al. Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Hum Mol Genet 16 (2007) 592-599
20. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347 (2002) 1916-1923
21. Monraats P.S., Kurreeman F.A., Pons D., et al. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention. Genes Immun 8 (2007) 44-50
22. Blacher J., Pannier B., Guerin A.P., et al. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32 (1998) 570-574
23. Juonala M., Järvisalo M.J., Mäki-Torkko N., et al. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study. Circulation 112 (2005) 1486-1493
24. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340 (1999) 14-22
25. Oliver J.J., and Webb D.J. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 23 (2003) 554-566
26. Raitakari O.T., Juonala M., Kähonen M., et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 290 (2003) 2277-2283
27. Burke G.L., Evans G.W., Riley W.A., et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 26 (1995) 386-391
28. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., and Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115 (2007) 459-467
29. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992) 1111-1115
30. Aggoun Y., Bonnet D., Sidi D., et al. Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 20 (2000) 2070-2075
31. Liang Y.L., Shiel L.M., Teede H., et al. Effects of blood pressure, smoking, and their interaction on carotid artery structure and function. Hypertension 37 (2001) 6-11
32. Tounian P., Aggoun Y., Dubern B., et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 358 (2001) 1400-1404
33. Raitakari O.T., Juonala M., Rönnemaa T., et al. Cohort profile: the cardiovascular risk in Young Finns Study. Int J Epidemiol 37 (2008) 1220-1226
34. Akerblom H.K., Viikari J., Uhari M., et al. Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross-sectional study of 1980, and an account of the children's and families' state of health. Acta Paediatr Scand Suppl 318 (1985) 49-63
35. Livak K.J. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14 (1999) 143-149
36. Excoffier L., Laval G., and Schneider S. Arlequin ver 3. 0: an integrated software package for population genetics data analysis. Evol Bioinform Online 1 (2005) 47-50
37. Donger C., Georges J.L., Nicaud V., et al. New polymorphisms in the interleukin-10 gene-relationships to myocardial infarction. Eur J Clin Invest 31 (2001) 9-14
38. Sumiyoshi S., Nakashima Y., Chen Y.X., Itabe H., and Sueishi K. Interleukin-10 expression is positively correlated with oxidized LDL deposition and inversely with T-lymphocyte infiltration in atherosclerotic intimas of human coronary arteries. Pathol Res Pract 202 (2006) 141-150
39. Halvorsen B., Waehre T., Scholz H., et al. Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. J Lipid Res 46 (2005) 211-219
40. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
41. Shifman S., and Darvasi A. The value of isolated populations. Nat Genet 28 (2001) 309-310
42. Peltonen L., Jalanko A., and Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet 8 (1999) 1913-1923
43. Samani N.J., Raitakari O.T., Sipila K., et al. Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosis. Arterioscler Thromb Vasc Biol 28 (2008) 1679-1683
44. Mälarstig A., Eriksson P., Hamsten A., et al. Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary symptoms. Heart 94 (2008) 724-729